CS276923B6 - Imunomodulačné prostriedky - Google Patents

Imunomodulačné prostriedky Download PDF

Info

Publication number
CS276923B6
CS276923B6 CS22790A CS22790A CS276923B6 CS 276923 B6 CS276923 B6 CS 276923B6 CS 22790 A CS22790 A CS 22790A CS 22790 A CS22790 A CS 22790A CS 276923 B6 CS276923 B6 CS 276923B6
Authority
CS
Czechoslovakia
Prior art keywords
mol
granulocytes
bromide
granulocyte
superoxide
Prior art date
Application number
CS22790A
Other languages
Czech (cs)
English (en)
Other versions
CS9000227A2 (en
Inventor
Ferdinand Doc Ing Csc Devinsky
Miroslav Doc Ing Drsc Ferencik
Ivan Ing Lacko
Dusan Doc Rndr Csc Mlynarcik
Original Assignee
Farmaceuticka Fakulta Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceuticka Fakulta Uk filed Critical Farmaceuticka Fakulta Uk
Priority to CS22790A priority Critical patent/CS276923B6/sk
Publication of CS9000227A2 publication Critical patent/CS9000227A2/cs
Publication of CS276923B6 publication Critical patent/CS276923B6/sk

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Riešenie sa týká imunomodulačných prostriedkov, ktoré majú ako aktivnu zložku vo svojej molekule amóniové bromidy uvedeného vzorca a obsahujú v molekule jeden alebo dva dlhé alkylové reíazce s počtom atómov uhlíka 11 až 14 a ktoré v závislosti na koncentrácii vykazujú bud imunosupresívny alebo imunostimulačný efekt. .Vzhíadom na tieto účinky je ich možné použit okrem iného v humánnej a veterinárnej medicíně a farmacii.
CS22790A 1990-01-17 1990-01-17 Imunomodulačné prostriedky CS276923B6 (sk)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS22790A CS276923B6 (sk) 1990-01-17 1990-01-17 Imunomodulačné prostriedky

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS22790A CS276923B6 (sk) 1990-01-17 1990-01-17 Imunomodulačné prostriedky

Publications (2)

Publication Number Publication Date
CS9000227A2 CS9000227A2 (en) 1991-07-16
CS276923B6 true CS276923B6 (sk) 1992-09-16

Family

ID=5334013

Family Applications (1)

Application Number Title Priority Date Filing Date
CS22790A CS276923B6 (sk) 1990-01-17 1990-01-17 Imunomodulačné prostriedky

Country Status (1)

Country Link
CS (1) CS276923B6 (sk)

Also Published As

Publication number Publication date
CS9000227A2 (en) 1991-07-16

Similar Documents

Publication Publication Date Title
Iacono et al. Selective antibacterial properties of lysozyme for oral microorganisms
Clark et al. The effects of Acacia arabica gum on the in vitro growth and protease activities of periodontopathic bacteria
MX9707732A (es) Compuestos triciclicos utiles en el tratamiento de desordenes proliferativos de celulas.
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
ES2175863T3 (es) Producto liofilizado que contiene beta-1,3-glucano procedente de euglena, su preparacion y utilizacion.
NO893021L (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
Tanzer et al. Structural requirements of guanide, biguanide, and bisbiguanide agents for antiplaque activity
Taichman et al. Interaction of inflammatory cells and oral bacteria: release of lysosomal hydrolases from rabbit polymorphonuclear leukocytes exposed to gram-positive plaque bacteria
EP2215910A1 (en) Quorum sensing inhibitor
Labro et al. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity
Vickerman et al. Sucrose-promoted accumulation of growing glucosyltransferase variants of Streptococcus gordonii on hydroxyapatite surfaces
Ciardi et al. The effect of antibacterial compounds on glucosyltransferase activity from Streptococcus mutans
Lochner et al. Defective triggering of polymorphonuclear leukocyte oxidative metabolism by Legionella pneumophila toxin
EP2077260A1 (en) Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof
CS276923B6 (sk) Imunomodulačné prostriedky
Von Graevenitz et al. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans
CS276929B6 (sk) Imunomodulačné prostriedky
ATE86994T1 (de) Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen.
KOBASHI et al. Therapy for urolithiasis by hydroxamic acids. II. Urease inhibitory potency and urinary excretion rate of hippurohydroxamic acid derivatives
Glazer et al. Effects of adenosine 3': 5'-monophosphate and related agents on ribonucleic acid synthesis and morphological differentiation in mouse neuroblastoma cells in culture.
MATsUDA Dextran degrading bacteria in human oral cavity and their activity against insoluble glucan from Streptococcus mutans
Lawrence Penicillin: reversible inhibition of forespore septum development in Bacillus megaterium cells
Pai et al. Uptake of pimelic acid by Escherichia coli and Pseudomonas denitrificans
Rojas-Espinosa et al. Phagocytosis in leprosy. 5. The effect of the infection with Mycobacterium lepraemurium on the level of diverse hydrolytic lysosomal enzymes of murine peritoneal macrophages